论文部分内容阅读
目的:了解精神病院门诊患者BZD类药物的使用状况,评价临床用药的合理性。方法:回顾性调查我院2002年6月―12月门诊处方,对其中使用BZD类药物的处方用药数据进行分析。结果:使用BZD类药物的处方约占17.8%。其中BZD单、联或加用其它镇静、催眠、抗焦虑药占37.36%;BZD+抗精神病药11.63%,BZD +抗抑郁药49.66%,BZD+抗“精”+“抑”药1.342%。结论:DUI值提示,氯硝安定、氟安定有一定滥用倾向;高比例联合用药,较长的服药周期必须引起临床高度重视。
Objective: To understand the use of BZD drugs in outpatients in psychiatric hospitals and to evaluate the rationality of clinical medication. Methods: A retrospective survey of our hospital from June to December 2002 outpatient prescriptions, prescription drugs which use BZD drugs were analyzed. Results: The prescription of BZD drugs accounted for about 17.8%. BZD alone or in combination with other sedation, hypnosis, anti-anxiety drugs accounted for 37.36%; BZD + antipsychotics 11.63%, BZD + antidepressants 49.66%, BZD + anti “essence” + “inhibition” drugs 1.342%. Conclusion: The DUI value suggests that clonazepam and flurazepam have a certain tendency of abuse. In the high proportion of combination therapy, the longer medication period must be paid great attention in clinic.